ICK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.300000E-01
Normal-vs-Stage2
8.150400E-01
Normal-vs-Stage3
1.545010E-01
Normal-vs-Stage4
3.957800E-01
Stage1-vs-Stage2
9.654000E-01
Stage1-vs-Stage3
3.952000E-01
Stage1-vs-Stage4
2.589200E-01
Stage2-vs-Stage3
2.653800E-01
Stage2-vs-Stage4
6.657900E-02
Stage3-vs-Stage4
9.329700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.000000E-01
Normal-vs-AfricanAmerican
7.617400E-01
Normal-vs-Asian
7.219600E-01
Caucasian-vs-AfricanAmerican
3.220400E-01
Caucasian-vs-Asian
8.741200E-01
AfricanAmerican-vs-Asian
4.039600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.511800E-01
Normal-vs-Female
6.162600E-01
Male-vs-Female
3.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.313400E-01
Normal-vs-Age(41-60Yrs)
9.324200E-01
Normal-vs-Age(61-80Yrs)
6.629000E-01
Normal-vs-Age(81-100Yrs)
6.571600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.837400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.791800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.582600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.889400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.625400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.088600E-01
Normal-vs-Daily Drinker
5.966600E-01
Normal-vs-Weekly Drinker
7.608600E-01
Normal-vs-Occasional Drinker
9.818600E-01
Normal-vs-Social Drinker
8.453600E-01
Non Drinker-vs-Daily Drinker
7.445800E-01
Non Drinker-vs-Weekly Drinker
5.613800E-01
Non Drinker-vs-Occasional Drinker
2.753800E-01
Non Drinker-vs-Social Drinker
4.826200E-01
Daily Drinker-vs-Weekly Drinker
5.190600E-01
Daily Drinker-vs-Occasional Drinker
3.006000E-01
Daily Drinker-vs-Social Drinker
4.613400E-01
Weekly Drinker-vs-Occasional Drinker
6.795800E-01
Weekly Drinker-vs-Social Drinker
9.070600E-01
Occasional Drinker-vs-Social Drinker
7.747400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.554750E-01
Normal-vs-Grade 2
5.331600E-02
Normal-vs-Grade 3
4.914100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.114300E-02
Grade 1-vs-Grade 3
1.932230E-01
Grade 1-vs-Grade 4
1.554750E-01
Grade 2-vs-Grade 3
5.186600E-01
Grade 2-vs-Grade 4
5.331600E-02
Grade 3-vs-Grade 4
4.914100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.087000E-01
Normal-vs-NonDiabetic
6.402600E-01
Diabetic-vs-NonDiabetic
8.067600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.513040E-01
Normal-vs-NoPancreatitis
7.070600E-01
Pancreatitis-vs-NoPancreatitis
9.019600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.246800E-01
Normal-vs-N1
7.822800E-01
N0-vs-N1
7.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.364400E-01
Normal-vs-TP53-NonMutant
9.359200E-01
TP53-Mutant-vs-TP53-NonMutant
9.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
